Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery.
about
Cervical squamous carcinoma cells are resistant to the combined action of tumor necrosis factor-alpha and histamine whereas normal keratinocytes undergo cytolysisTumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed.Current status of antivascular therapy and targeted treatment in the clinic.Is cancer a severe delayed hypersensitivity reaction and histamine a blueprint?Tumor vasculature as target for therapeutic intervention.Isolated limb infusion as a model to test new agents to treat metastatic melanoma.
P2860
Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Histamine, a vasoactive agent ...... enhancing local drug delivery.
@ast
Histamine, a vasoactive agent ...... enhancing local drug delivery.
@en
type
label
Histamine, a vasoactive agent ...... enhancing local drug delivery.
@ast
Histamine, a vasoactive agent ...... enhancing local drug delivery.
@en
prefLabel
Histamine, a vasoactive agent ...... enhancing local drug delivery.
@ast
Histamine, a vasoactive agent ...... enhancing local drug delivery.
@en
P2093
P2860
P356
P1476
Histamine, a vasoactive agent ...... enhancing local drug delivery.
@en
P2093
A M M Eggermont
F Brunstein
S T van Tiel
T L M ten Hagen
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603461
P407
P577
2006-11-14T00:00:00Z
P5875
P6179
1047540882